Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2022 01:00 ET | Source: Biocartis NV

Persbericht Biocartis Group NV: Nieuwe studie geleid door Memorial Sloan Kettering Cancer Center (NY, VS) toont dat Idylla™ GeneFusion Assay snellere screening van gerichte genfusies toelaat in vergelijking met routinemethoden

PERSBERICHT: 4 mei 2022, 07:00 CEST Nieuwe studie geleid door Memorial Sloan Kettering Cancer Center (NY, VS) toont dat Idylla™ GeneFusion Assay snellere screening van gerichte genfusies toelaat in...
May 04, 2022 01:00 ET | Source: Biocartis NV

Press release Biocartis Group NV: New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to Routine Methods

PRESS RELEASE: 4 May 2022, 07:00 CEST New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to...